Isolation of a Second Recombinant Human Respiratory Syncytial Virus Monoclonal Antibody Fragment (Fab RSVF2–5) that Exhibits Therapeutic Efficacy In Vivo

James E. Crowe, Jr., Page S. Gilmour, Brian R. Murphy, Robert M. Chanock, Lingxun Duan, Roger J. Pomerantz, Glenn R. Pilkington
  • The Journal of Infectious Diseases, April 1998, Oxford University Press (OUP)
  • DOI: 10.1086/517397

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr James E Crowe